Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Telmisartan vs. Losartan in Hypertensive Patients With Impaired Glucose Tolerance: A Comparison of Their Antihypertensive, Metabolic, and Vascular Effects

NCT00407862 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT00407862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00407862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Telmisartan vs. Losartan in Hypertensive Patients With Impaired Glucose Tolerance: A Comparison of Their Antihypertensive, Metabolic, and Vascular Effects
Lead sponsor
Medical University of Graz
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2005
Completion date
June 30, 2006
Enrollment
24
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, impaired glucose tolerance